TATA-box-binding protein-associated factor 11-like protein 5 (TAF11L5)

TATA-box-binding protein-associated factor 11-like protein 5 (TAF11L5) is a predicted nuclear protein involved in RNA polymerase II general transcription initiation, likely acting as a component of the transcription factor TFIID complex supporting preinitiation complex assembly[1][3][5][7]. Its designation as a "pseudogene" in some contexts and minimal literature on its direct functional roles, therapeutic targeting, or disease associations suggest it is not considered a validated therapeutic target or a well-characterized biological molecule in clinical or pharmacological research[1]. Notes: - The target is not established as a conventional therapeutic target, receptor, or enzyme. It is designated a *pseudogene* by some sources and lacks evidence of direct involvement in disease mechanisms or drug action[1]. - There is no information on drugs, mechanisms of action, biomarkers, or safety concerns, confirming its non-target status in drug discovery contexts. - The function is inferred from gene annotation databases; direct experimental or clinical relevance is missing[1][3][7]. If you seek information on a validated and actionable drug target, a different gene/protein might be required.

Other names

TATA-box binding protein associated factor 11 like 5TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa pseudogeneTFKL5 Protein